Cleared Traditional

K070831 - VOXAR 3D ENTERPRISE WITH COLONMETRIX AND PET/CT PERFUSION

K070831 is an FDA 510(k) clearance for VOXAR 3D ENTERPRISE WITH COLONMETRIX AN..., manufactured by Barcoview Mis Edinburgh. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 57-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2007
Decision
57d
Days
Class 2
Risk

K070831 is an FDA 510(k) clearance for the VOXAR 3D ENTERPRISE WITH COLONMETRIX AND PET/CT PERFUSION. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Barcoview Mis Edinburgh (Edinburgh, Lothian, GB). The FDA issued a Cleared decision on May 22, 2007 after a review of 57 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

FDA 510(k) Submission Details - K070831

510(k) Number K070831 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 26, 2007
Decision Date May 22, 2007
Days to Decision 57 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Statement
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
50d faster than avg
Panel avg: 107d · This submission: 57d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Underwriters Laboratories, Inc.
JEFF D RONGERO

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2282
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K070831.
VITAL CONNECT 4.1
K071362 · Vital Images, Inc. · May 2007
VITREA VERSION 4.0
K071331 · Vital Images, Inc. · May 2007
5MP MEDICAL MONOCHROME REFERENCE DISPLAY, MODEL MDM2010-5NC
K063269 · Chi Lin Technology Co., Ltd. · May 2007
RADIODEXTER, DEXTROSCOPE, DEXTROBEAM, MODELS 1.0, MK10, MK3 & MK4
K071054 · Volume Interactions Pte, Ltd. · May 2007
SYNGO IMAGING (VERSION V30)
K071114 · Siemens AG Medical Solutions · May 2007
LMS-LUNG/TRACK
K070868 · Median Technologies · May 2007